Physical exercise during neoadjuvant chemotherapy for breast cancer as a mean to increase pathological complete response rates: Trial protocol of the randomized Neo-ACT trial

被引:7
|
作者
de Boniface, Jana [1 ,2 ]
Altena, Renske [3 ,4 ]
Ringborg, Cecilia Haddad [5 ]
Bolam, Kate A. [5 ]
Wengstrom, Yvonne [5 ,6 ]
机构
[1] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
[2] Capio St Gorans Hosp, Dept Surg, Stockholm, Sweden
[3] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[4] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden
[5] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Nursing, Stockholm, Sweden
[6] Karolinska Univ Hosp, Karolinska Comprehens Canc Ctr, Stockholm, Sweden
来源
PLOS ONE | 2022年 / 17卷 / 10期
基金
瑞典研究理事会;
关键词
WEEKLY PACLITAXEL; MECHANISMS;
D O I
10.1371/journal.pone.0274804
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction In early breast cancer, neoadjuvant chemotherapy (NACT) is increasingly used. The proof of efficacy is pathologically complete response (pCR), i.e. the absence of invasive tumour in breast and lymph nodes at surgery. Today, pCR is a common endpoint in pharmaceutical trials since it is significantly associated with survival especially in triple-negative and HER2-positive subtypes. Apart from the mitigation of treatment-related toxicity and symptoms, physical exercise mediates anti-tumoral systemic effects associated with tumour regression in preclinical and clinical models. The aim of Neo-ACT is to test the hypothesis that physical exercise can improve pCR rates in breast cancer patients receiving NACT. Method The Neo-ACT trial is a prospective clinical trial, randomising T1-3N0-2 breast cancer patients planned for NACT to either a home-based physical exercise intervention supported by a mobile application or routine care. The primary endpoint is pCR; secondary endpoints are patient-reported quality of life, toxicity-related outcomes, and oncological outcomes such as Residual Cancer Burden, objective radiological tumour response, as well as overall, breast cancer-specific and disease-free survival at 2, 5 and 10 years. The intervention consists of a combination of high-intensity interval and resistance training of progressing intensity, and includes at least 150 min of moderate to vigorous physical activity per week, inclusive of two weekly 60-min exercise sessions. In order to show an improvement in pCR of 10%, a total of 712 participants need to be included in the analysis. The Neo-ACT has been registered at clinicaltrials.gov on January 11, 2022 (NCT05184582). Expected results If Neo-ACT can prove the oncological efficacy of physical exercise, implementation of training programmes into NACT schedules will be pursued. The use of a digitally led exercise intervention aims to test the potential of such a strategy for use in rural areas and areas of limited resources.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Motivation for Different Types and Doses of Exercise During Breast Cancer Chemotherapy: a Randomized Controlled Trial
    Courneya, Kerry S.
    Segal, Roanne J.
    Vallerand, James R.
    Forbes, Cynthia C.
    Crawford, Jennifer J.
    Dolan, Lianne B.
    Friedenreich, Christine M.
    Reid, Robert D.
    Gelmon, Karen
    Mackey, John R.
    McKenzie, Donald C.
    ANNALS OF BEHAVIORAL MEDICINE, 2016, 50 (04) : 554 - 563
  • [22] MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer
    Briete Goorts
    Kelly M. A. Dreuning
    Janneke B. Houwers
    Loes F. S. Kooreman
    Evert-Jan G. Boerma
    Ritse M. Mann
    Marc B. I. Lobbes
    Marjolein L. Smidt
    Breast Cancer Research, 20
  • [23] MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer
    Goorts, Briete X. Z.
    Dreuning, Kelly M. A.
    Houwers, Janneke B.
    Kooreman, Loes F. S.
    Boerma, Evert-Jan G.
    Mann, Ritse M.
    Lobbes, Marc B. I.
    Smidt, Marjolein L.
    BREAST CANCER RESEARCH, 2018, 20
  • [24] Can body mass index be a complete pathological response predictor in breast cancer patients submitted to neoadjuvant chemotherapy? A real-world data trial
    Richter, Fernanda Grace Bauk
    Mattar, Andre
    Antonini, Marcelo
    Real, Juliana
    Gebrim, Luis Henrique
    Lopes, Reginaldo Coelho
    CANCER RESEARCH, 2024, 84 (09)
  • [25] Pathological complete response rates in patients with BRCA1/2-associated breast cancer after neoadjuvant chemotherapy
    Richters, L.
    Rhiem, K.
    Wappenschmidt, B.
    Kiechle, M.
    Schmutzler, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 13 - 14
  • [26] Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study
    Sanft, Tara
    Harrigan, Maura
    McGowan, Courtney
    Cartmel, Brenda
    Zupa, Michelle
    Li, Fang-Yong
    Ferrucci, Leah M.
    Puklin, Leah
    Cao, Anlan
    Nguyen, Thai Hien
    Neuhouser, Marian L.
    Hershman, Dawn L.
    Basen-Engquist, Karen
    Jones, Beth A.
    Knobf, Tish
    Chagpar, Anees B.
    Silber, Andrea
    Tanasijevic, Anna
    Ligibel, Jennifer A.
    Irwin, Melinda L.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (34) : 5285 - +
  • [27] Effects of exercise therapy on chemotherapy delivery and response in primary breast cancer: A secondary analysis of a randomized trial
    Iyengar, Neil M.
    Scott, Jessica M.
    Lee, Jasme
    Lavery, Jessica A.
    Foug, Katherine L.
    Lee, Catherine P.
    Michalski, Meghan G.
    Chun, Su S.
    Harrison, Jenna
    Moskowitz, Chaya S.
    Jones, Lee W.
    CANCER, 2025, 131 (01)
  • [28] Recruitment to and pilot results of the PACES randomized trial of physical exercise during adjuvant chemotherapy for colon cancer
    van Waart, Hanna
    Stuiver, Martijn M.
    van Harten, Wim H.
    Geleijn, Edwin
    de Maaker-Berkhof, Marianne
    Schrama, Jolanda
    Geenen, Maud M.
    Terwogt, Jetske M. Meerum
    van den Heiligenberg, Simone M.
    Hellendoorn-van Vreeswijk, Jeannette A. J. H.
    Sonke, Gabe S.
    Aaronson, Neil K.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2018, 33 (01) : 29 - 40
  • [29] Recruitment to and pilot results of the PACES randomized trial of physical exercise during adjuvant chemotherapy for colon cancer
    Hanna van Waart
    Martijn M. Stuiver
    Wim H. van Harten
    Edwin Geleijn
    Marianne de Maaker-Berkhof
    Jolanda Schrama
    Maud M. Geenen
    Jetske M. Meerum Terwogt
    Simone M. van den Heiligenberg
    Jeannette A. J. H. Hellendoorn-van Vreeswijk
    Gabe S. Sonke
    Neil K. Aaronson
    International Journal of Colorectal Disease, 2018, 33 : 29 - 40
  • [30] Reduced symptom burden with the support of an interactive app during neoadjuvant chemotherapy for breast cancer - A randomized controlled trial
    Fjell, Maria
    Langius-Eklof, Ann
    Nilsson, Marie
    Wengstrom, Yvonne
    Sundberg, Kay
    BREAST, 2020, 51 : 85 - 93